Benitec Biopharma Inc.

NASDAQ:BNTC

Biotechnology

Healthcare
$8.27 +3.05%

+$0.36 today

Market cap
$288.53M
Beta
0.28
P/E (TTM)
-12.3
EPS (TTM)
-$0.99
52W Low $9.85High $16.76

Volume 0.13M

Average 0.11M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$23.59M

FY 2025 · Annual

Investing Cash Flow

-$18,000.00

FY 2025 · Annual

Financing Cash Flow

$70.48M

FY 2025 · Annual

+3.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income(13.88M)(18.21M)(19.56M)(21.75M)(37.92M)
Depreciation & Amortization424K392K381K343K396K
Deferred Income Tax00(714K)00
Stock-Based Compensation634K870K452K830K17.43M
Change in Working Capital8K1.04M714K1.17M(2.73M)
Accounts Receivables28K1K(50K)(176K)197K
Inventory(83K)(1.09M)(1.31M)00
Accounts Payables55K1.09M1.36M0(2.38M)
Other Working Capital8K1.04M714K1.35M(548K)
Other Non-Cash Items(16K)10K717K1K(764K)
Operating Cash Flow(12.83M)(15.9M)(18.01M)(19.4M)(23.59M)
Capital Expenditures(221K)(13K)(1K)(179K)(18K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(221K)(13K)(1K)(179K)(18K)
Debt Repayment00000
Common Stock Issued25.75M017.88M70.88M70.49M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.23M)0(1.87M)(2.85M)0
Financing Cash Flow22.52M016.02M68.03M70.49M
Effect of Forex Changes499K204K412K(8K)49K
Net Change in Cash9.97M(15.71M)(1.59M)48.44M46.93M
Free Cash Flow(13.05M)(15.91M)(18.01M)(19.58M)(23.61M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$37.9M
+ D&A$396.0K
+ Stock-Based Comp$17.4M
+ Deferred Tax$0
- Working Capital-$2.7M
- Other Non-Cash-$764.0K
= Operating Cash Flow-$23.6M
- Capex-$18.0K
= Free Cash Flow-$23.6M

Analysis

FY2025 free cash flow is -$23.6M. FCF conversion is 62.3% of net income. Operating cash flow was -$23.6M, with capex of -$18.0K. The largest bridge item is Stock-Based Comp at $17.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
8-KCurrent reportOct 28, 2026
DEFA14ADEFA14A filingOct 20, 2026
DEF 14ADEF 14A filingOct 20, 2026

Does BNTC generate free cash flow?

Benitec Biopharma Inc. (BNTC) generated -$23.61M of free cash flow in fiscal 2025.

How much operating cash flow does BNTC produce?

Operating cash flow was -$23.59M, before capital expenditures of $18,000.00.